Applying Genomics

Core Concepts

Finding genes that cause disease

Rare diseases caused by a single gene (cystic fibrosis, Huntington's disease — commonly taught examples) can be located through linkage analysis in affected families. Most common diseases (heart disease, type 2 diabetes) are polygenic — many genes each contribute a small effect. To find those genes, researchers run genome-wide association studies (GWAS): they compare millions of single nucleotide polymorphisms (SNPs) — single-base differences between individuals — across large groups of affected and unaffected people, looking for variants that appear more often in the affected group. A key exam point: GWAS finds associations (correlations), not proof that a variant causes the disease; follow-up functional studies are required.

Pharmacogenomics: matching the drug to the genotype

People respond differently to the same drug, and much of that variation is genetic. Pharmacogenomics studies how gene variants affect drug metabolism and response. Commonly taught examples include variants in cytochrome P450 enzymes (which metabolize many drugs), the enzyme TPMT (variants increase risk of severe toxicity from thiopurine drugs), and warfarin sensitivity, where dosing is influenced by multiple gene variants. Testing a person's relevant genes before prescribing can predict who will respond well, who needs a different dose, and who is at risk of serious adverse reactions. (Educational examples only — actual prescribing decisions follow current clinical guidelines.)

Cancer genomics

Cancer is a disease of the genome: tumors accumulate somatic mutations — in oncogenes (which promote growth when overactive), tumor-suppressor genes (which restrain growth when inactivated), and DNA-repair genes — that together drive uncontrolled division. Sequencing a tumor's DNA reveals its "drivers"; some of these mutations predict response to targeted therapies (commonly taught examples: HER2 amplification in breast cancer, EGFR mutations in lung cancer). This is why patients with the same cancer type may receive very different treatments based on their tumor's genomic profile.

Microbial and infectious-disease genomics

Sequencing pathogen genomes can identify a species, reveal which antibiotic-resistance genes it carries, and trace transmission: when hospital patients share a nearly identical bacterial strain, the infections likely share a common source, guiding infection control. Whole-genome sequencing of viruses has been central to monitoring emerging variants (widely seen during the SARS-CoV-2 pandemic — commonly taught current example). Genomics also informs vaccine design and surveillance of drug-resistant strains.

Agriculture and the environment

Breeders use marker-assisted selection — picking parents based on mapped DNA markers rather than waiting to see traits — to speed up crop and livestock improvement. Genetically modified crops are produced by inserting engineered genes; commonly cited examples include insect-resistant Bt crops, herbicide-tolerant crops, and golden rice, engineered to produce provitamin A. Meanwhile, metagenomics sequences DNA directly from environmental or community samples (soil, ocean water, the human gut microbiome), revealing organisms that cannot be cultured in the lab — a census of entire ecosystems from a single sample.

Ethics, privacy, and law

Genomic information is unusual: it is permanent, it is predictive, and it concerns relatives as well as the tested individual. Direct-to-consumer genetic tests raise questions about consent and interpretation — ancestry estimates are not medical diagnoses. In the United States, the Genetic Information Nondiscrimination Act (GINA) (commonly taught) prohibits health-insurance companies and employers from discriminating on the basis of genetic information; laws in other countries differ and continue to evolve. Responsible use of genomics therefore requires counseling, informed consent, and attention to privacy.

Common Confusions